ITRM, FDA trial to resume?We are down alot on this, hoping for the break and taking back some capital.
ITRM
$ITRM Bullish July swing$ITRM PDUFA JULY 25. Expect heavier volume to come in as we get closer to date. First PT 3$, second $4.20, last PT 5$. Take profits on the way up.
Familiar T/A on ITRM Well, doesn't this look familiar? ITRM tested is previous level of support AND resistance in a wide channel today. IDK what the sell-off was but I'm guessing the re-entry had something to do with speculation on the FDA data set to come out next month.
"At the end of May, Iterum provided an update on its New Drug Application with the U.S. Food and Drug Administration. Currently, the NDA is still under review by the FDA, and the PDUFA goal date is July 25th, 2021. Since the application review for Sulopenem is on track at the moment, ITRM stock is performing well as a result. ITRM stock price has nearly doubled in the last month."
Not sure if it gets the approvals necessary but "buy the rumor" might be playing a role here.
Quote Source: Top 9 Penny Stocks With High Volume to Watch Right Now
Double Bottom on Weekly $ITRM chart.Sitting above the 200ma and residing within the upper portion of the donchian channel, ITRM seems to be in a positively trending with lots of upward room for growth. I'm currently using a combination of the Chandelier exit and Donchian Channel indicators to plan for an exit.
